Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capn4 contributes to tumor invasion and metastasis in gastric cancer via activation of the Wnt/β-catenin/MMP9 signalling pathways.

Experimental cell research·2020
Same author

Biocompatibility evaluation of heparin-conjugated poly(ε-caprolactone) scaffolds in a rat subcutaneous implantation model.

Journal of materials science. Materials in medicine·2020
Same author

Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer.

Oncology letters·2020
Same author

Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.

International journal of oncology·2020
Same author

Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells.

Medical science monitor : international medical journal of experimental and clinical research·2020
Same author

Management of Postoperative Pain after Elective Craniotomy: A Prospective Randomized Controlled Trial of a Neurosurgical Enhanced Recovery after Surgery (ERAS) Program.

International journal of medical sciences·2020

Related Experiment Video

Updated: Jun 5, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.

Lin Ye1, Malcolm D Mason, Wen G Jiang

  • 1Metastasis and Angiogenesis Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK. yel@cf.ac.uk

Frontiers in Bioscience (Landmark Edition)
|January 4, 2011
PubMed
Summary

Bone morphogenetic proteins (BMPs) are increasingly implicated in the development of bone metastasis, a severe complication of advanced cancers like breast, prostate, and lung cancer. Understanding BMP signaling is crucial for targeting this incurable condition.

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Related Experiment Videos

Last Updated: Jun 5, 2026

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Skeletal Biology

Background:

  • Bone metastasis is a severe complication of advanced cancers, notably breast, prostate, and lung cancer, leading to significant morbidity.
  • The underlying mechanisms of bone metastasis development are not fully understood.
  • Bone morphogenetic proteins (BMPs), regulators of cellular processes, are involved in embryonic development and tissue homeostasis.

Purpose of the Study:

  • To review the current understanding of Bone Morphogenetic Proteins (BMPs) and their role in tumor progression.
  • To specifically investigate the involvement of BMP signaling pathways and their antagonists in the development of bone metastasis.
  • To highlight aberrations in BMPs associated with skeletal metastasis.

Main Methods:

  • Literature review of studies investigating BMPs in cancer and bone metastasis.
  • Analysis of current knowledge on BMP signaling pathways and their antagonists in skeletal metastasis.
  • Synthesis of findings on BMP aberrations in tumor progression and bone metastasis.

Main Results:

  • BMPs are implicated in various neoplasms, including primary and secondary tumors, with a particular focus on skeletal metastasis.
  • Recent studies suggest a pivotal role for BMP signaling and its antagonists in the development of bone metastasis.
  • Aberrations in BMPs are indicated as contributors to tumor progression and the establishment of bone metastasis.

Conclusions:

  • BMP signaling pathways and their antagonists are critical players in the pathogenesis of bone metastasis.
  • Further research into BMPs offers potential therapeutic targets for managing bone metastasis in advanced malignancies.
  • Understanding BMP aberrations is key to addressing the mechanisms driving skeletal metastasis.